The Global next generation sequencing market was estimated to be $4,146.9 million in 2016 and is projected to reach $11,925.2 million, witnessing a CAGR of 13.61% for the forecast period from 2017 to 2024.
With huge increase in demand for genome mapping programs and diagnostics tests based on sequencing, NGS market is expected to witness impressive growth and promises to be a lucrative field for investment. In addition, the field of service providers for sequencing tests and the applications based on genome sequencing is perceived to be a lucrative business all over the globe. With the impressive rise in demand for sequencing based diagnostics applications namely NIPT and liquid biopsy, the service providing companies have gained popularity and acceptance all over the globe.
Sequencing of first human genome by utilizing sanger sequencing technology took around 15 years, while costing approximately $2.7 billion. Impressive advancement in field of technical engineering, molecular biology, and sequencing chemistry have profoundly effected the sequencing efficiency. This has paved the way for the development of Next Generation Sequencing (NGS).
NGS is a massively parallel, high-throughput sequencing technology which allows sequencing of million of fragments in a single run. To date, evolution of NGS technology has drastically decreased the cost of sequencing from $10 million to $1000. And further progress of NGS technology is expected to decrease the sequencing cost to $100.
Key Topics Covered:
1 Executive Summary
2 Report Scope and Methodology
3 Market Dynamics
4 Competitive Landscape
5 Funding Scenario
6 Global Next Generation Sequencing Market, by Technology
7 Global Next Generation Sequencing Market, by Product
8 Global Next Generation Sequencing Market, by Application
9 Global Next Generation Sequencing Market, by Geography
10 Company Profiles
- 10x Genomics
- Agilent Technologies, Inc.
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- GATC Biotech AG.
- GenapSys, Inc.
- Illumina, Inc.
- New England Biolabs, Inc.
- NuGEN Technologies Inc.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California, Inc.
- Partek, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/nc824s/next_generation